Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Prepaid Assets (2016 - 2025)

Collegium Pharmaceutical has reported Prepaid Assets over the past 10 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $3.2 million for Q4 2025, up 18.13% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (up 18.13% YoY), and the annual figure for FY2025 was $3.2 million, up 18.13%.
  • Prepaid Assets for Q4 2025 was $3.2 million at Collegium Pharmaceutical, down from $36.2 million in the prior quarter.
  • Over the last five years, Prepaid Assets for COLL hit a ceiling of $56.0 million in Q2 2025 and a floor of $57000.0 in Q4 2022.
  • Median Prepaid Assets over the past 5 years was $11.4 million (2022), compared with a mean of $16.1 million.
  • Biggest five-year swings in Prepaid Assets: plummeted 98.42% in 2022 and later soared 4598.25% in 2023.
  • Collegium Pharmaceutical's Prepaid Assets stood at $3.6 million in 2021, then plummeted by 98.42% to $57000.0 in 2022, then soared by 4598.25% to $2.7 million in 2023, then grew by 2.39% to $2.7 million in 2024, then increased by 18.13% to $3.2 million in 2025.
  • The last three reported values for Prepaid Assets were $3.2 million (Q4 2025), $36.2 million (Q3 2025), and $56.0 million (Q2 2025) per Business Quant data.